Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$7.07 - $15.69 $641,779 - $1.42 Million
90,775 New
90,775 $837,000
Q3 2022

Nov 14, 2022

BUY
$12.56 - $22.53 $107,463 - $192,766
8,556 Added 11.95%
80,180 $1.03 Million
Q2 2022

Aug 15, 2022

BUY
$10.36 - $23.93 $92,473 - $213,599
8,926 Added 14.24%
71,624 $947,000
Q1 2022

May 11, 2022

BUY
$17.19 - $26.1 $14,388 - $21,845
837 Added 1.35%
62,698 $1.32 Million
Q4 2021

Feb 11, 2022

BUY
$18.11 - $30.72 $34,843 - $59,105
1,924 Added 3.21%
61,861 $1.48 Million
Q3 2021

Nov 12, 2021

BUY
$23.65 - $34.44 $131,612 - $191,658
5,565 Added 10.24%
59,937 $1.53 Million
Q2 2021

Aug 11, 2021

BUY
$30.53 - $41.09 $97,451 - $131,159
3,192 Added 6.24%
54,372 $1.83 Million
Q1 2021

May 13, 2021

SELL
$36.08 - $69.81 $110,224 - $213,269
-3,055 Reduced 5.63%
51,180 $1.99 Million
Q4 2020

Feb 09, 2021

BUY
$33.62 - $61.93 $177,547 - $327,052
5,281 Added 10.79%
54,235 $3.36 Million
Q3 2020

Nov 12, 2020

SELL
$22.23 - $37.48 $46,460 - $78,333
-2,090 Reduced 4.09%
48,954 $1.64 Million
Q2 2020

Aug 12, 2020

SELL
$20.26 - $29.73 $125,976 - $184,861
-6,218 Reduced 10.86%
51,044 $1.22 Million
Q1 2020

May 06, 2020

BUY
$16.8 - $34.15 $396,160 - $805,291
23,581 Added 70.01%
57,262 $1.31 Million
Q4 2019

Feb 14, 2020

BUY
$20.01 - $30.79 $181,810 - $279,757
9,086 Added 36.94%
33,681 $953,000
Q3 2019

Nov 07, 2019

BUY
$20.53 - $37.72 $504,935 - $927,723
24,595 New
24,595 $528,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $367M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.